TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $6.94 million. The enterprise value is $3.02 million.
| Market Cap | 6.94M |
| Enterprise Value | 3.02M |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TNFA has 1.77 million shares outstanding. The number of shares has increased by 237.42% in one year.
| Current Share Class | 1.77M |
| Shares Outstanding | 1.77M |
| Shares Change (YoY) | +237.42% |
| Shares Change (QoQ) | +193.45% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 0.30% |
| Float | 1.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93
| Current Ratio | 0.93 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -115.40% and return on invested capital (ROIC) is -87.01%.
| Return on Equity (ROE) | -115.40% |
| Return on Assets (ROA) | -24.00% |
| Return on Invested Capital (ROIC) | -87.01% |
| Return on Capital Employed (ROCE) | -72.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.26M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.82% in the last 52 weeks. The beta is 2.28, so TNFA's price volatility has been higher than the market average.
| Beta (5Y) | 2.28 |
| 52-Week Price Change | -96.82% |
| 50-Day Moving Average | 8.48 |
| 200-Day Moving Average | 43.20 |
| Relative Strength Index (RSI) | 35.75 |
| Average Volume (20 Days) | 831,859 |
Short Selling Information
| Short Interest | 5.72M |
| Short Previous Month | 5.20M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.07 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.36M |
| Pretax Income | -12.29M |
| Net Income | -10.53M |
| EBITDA | n/a |
| EBIT | -8.36M |
| Earnings Per Share (EPS) | -$159.52 |
Balance Sheet
The company has $3.81 million in cash and n/a in debt, giving a net cash position of $3.81 million or $2.16 per share.
| Cash & Cash Equivalents | 3.81M |
| Total Debt | n/a |
| Net Cash | 3.81M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 11.60M |
| Book Value Per Share | 17.47 |
| Working Capital | -397,585 |
Cash Flow
| Operating Cash Flow | -9.26M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TNFA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -237.42% |
| Shareholder Yield | -237.42% |
| Earnings Yield | -154.02% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 2, 2025. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |